KalVista Pharmaceuticals
KALV • NASDAQ • Stock Fundamentals
KalVista Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Benjamin L. Palleiko, with a market cap of $1.4B.
Market Cap$1.4B
Employees150.0
CEOBenjamin L. Palleiko
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 15, 2026 · 13 days agoQ4 2025
View reportNext EarningsAug 13, 2026 · in 3 monthsBefore Market Open · Q3 2026
Financials
Based on Q4 2025 filing
KalVista Pharmaceuticals FAQ
Common questions about KalVista Pharmaceuticals
KalVista Pharmaceuticals (KALV) has a market capitalization of $1.4B and trades on NASDAQ.
KalVista Pharmaceuticals has approximately 150 employees.